ADYX — Adynxx Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $8.41m
- $2.22m
Brief: Alliqua Biomedical says Company, unit and perceptive entered into amendment No.2 to forbearance and amendment agreement
Brief: Alliqua Biomedical says co, Perceptive enters amendment to reduce exercise price
Brief: Alliqua Biomedical Inc receives extension from Nasdaq to regain compliance with minimum bid price requirement
Brief: Alliqua Biomedical sees Q1 revenue about $4.6 million
Brief: Alliqua Biomedical to present new data at the spring 2017 symposium on advanced wound care
Brief: Alliqua Biomedical announces closing of about $3.8 mln public offering
Brief: Alliqua Biomedical announces pricing of public offering of common stock
Brief: Alliqua Biomedical plans to sell shares in public offering
Brief: Alliqua Biomedical says co and Celgene entered into side letter agreement
Brief: Alliqua says on March 7, 2017, co, unit and perceptive credit holdings entered into amendment no.1 to forbearance and amendment agreement
Brief: Alliqua Biomedical Q4 gaap loss per share $0.61
Brief: Alliqua Biomedical Inc announces termination of its agreement to acquire Soluble Systems Llc
Brief: Alliqua Biomedical enters into an amendment to forbearance agreement dated november 1, 2016
Brief: Alliqua Biomedical reports Q3 GAAP loss per share $0.30
Brief: Alliqua Biomedical says Medicare coverage for MIST Therapy now includes all Medicare administrative contractors
Brief: Alliqua Biomedical to acquire Soluble Systems
Brief: Alliqua BioMedical sees Q3 revenue about $4.85 million
Brief: Alliqua Biomedical Inc Q2 adjusted loss per share $0.19
Brief: Alliqua Biomedical sees 2016 revenue $20 mln to $22 mln